Compugen (CGEN) Capital Leases (2009 - 2013)

Compugen's (CGEN) quarterly Capital Leases came in at $22000.0 in Q2 2013, down 67.65% year-on-year from $68000.0 in Q2 2012, and down 63.33% quarter-over-quarter from $60000.0 in Q1 2013.

Compugen (CGEN) Capital Leases (2009 - 2013) Analysis & Trends

Compugen has disclosed Capital Leases across 5 years of filings, most recently posting $22000.0 for Q2 2013.

  • Capital Leases for Q2 2013 came in at $22000.0, down 67.65% year-over-year; the trailing twelve-month figure through Jun 2013 was $22000.0 (down 67.65% YoY), and the FY2012 annual result was $59000.0, up 247.06% from the prior year.
  • Capital Leases came in at $22000.0 for Q2 2013 at Compugen, down from $60000.0 in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $68000.0 in Q2 2012 to a low of $13000.0 in Q1 2010.
  • The 5-year median for Capital Leases is $25500.0 (2009), against an average of $34333.3.
  • Across the five-year window, Capital Leases surged 247.06% in 2012 and plunged 67.65% in 2013, its largest moves.
  • Compugen's Capital Leases stood at $18000.0 in 2009, then declined by 11.11% to $16000.0 in 2010, then rose by 6.25% to $17000.0 in 2011, then soared by 247.06% to $59000.0 in 2012, then tumbled by 62.71% to $22000.0 in 2013.
  • The last three Capital Leases figures came in at $22000.0 (Q2 2013), $60000.0 (Q1 2013), and $59000.0 (Q4 2012), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Compugen 189.59 Mn 97.83 Mn 352,000.00

Historic Data

Download Data
DateValue
Jun 30, 2013 22,000.00
Mar 31, 2013 60,000.00
Dec 31, 2012 59,000.00
Sep 30, 2012 60,000.00
Jun 30, 2012 68,000.00
Dec 31, 2011 17,000.00
Sep 30, 2010 16,000.00
Jun 30, 2010 18,000.00
Mar 31, 2010 13,000.00
Dec 31, 2009 18,000.00
Jun 30, 2009 29,000.00
Mar 31, 2009 32,000.00